Exact Sciences

Youtube Subscribe

Open: 68.15 Close: 65.9 Change: -2.25

14 risks of investing in Exact Sciences Company Inc Stock found by an AI after reading the whole internet.

The game is changing. There is a new strategy to evaluate Exact Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Exact Sciences are: Sciences, Exact, stock, price, EXAS, signal, NASDAQEXAS, …

Concept Map

Semantic Network

Stock Summary

Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. CFO Jeffrey Thomas Elliott sold 30,210 shares of Exacts Sciences stock in a transaction that occurred on Monday.

Today's Summary

Goldman Sachs Group cut target price on Exacts Sciences from $100 to $90.00 and set a buy rating on the stock. Goldman Sachs cut their target price at $100.00 in a research report on Friday. Exact Sciences Corporation provides cancer screening and diagnostic test products.

Today's News

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Defense World Staff on Dec 16th, 2023. Bokf Na lowered its position in shares of Exacts Sciences. Bernstein Initiates Coverage On Exact Sciences With Outperform Rating, Announces Price Target of $83. Exact Science ranks 2 nd among 148 competitors, of which 123 are active. Exact Sciences beats Many Bright Ideas Technologies on 5 of the 8 factors compared between the two stocks. Exact sciences has a consensus price target of $96.47, indicating a potential upside of 42.48%. Exact Sciences (NASDAQ:EXAS) Pulls Back 4.3% this week, but still Delivers Shareholders Splendid 104% Return Over 1 Year. Cantor Fitzgerald Cuts Mainz to Neutral, Cites Liquidity Concerns. Exact Science awards $1.3M in Grants. Exact Sciences (NASDAQ:EXAS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3 0 0 0. In the last 3 months, 5 analysts have offered 12-month price targets for Exacts Sciences. Exact Sciences has a 12-month low of $43.90 and a high of $100.7777. Goldman Sachs Group cut their target price on Exacts Sciences from $100 to $90.00 and set a buy rating on the stock in a research report on Friday. Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The value of EXACT Sciences shares will drop by -3.63% and reach $ 63.51 per share by December 21, 2023. According to our current EXAS stock forecast, its now a bad time to buy EXAS. EXACT Sciences stock forecast sentiment is bearish   with 5 technical analysis indicators signaling bullish signals, and 21 signaling bearish signals. If this EXAS stock prediction for 2030 materializes, EXAS willgrow 944.10% from its current price.

Stock Profile

" Exact Sciences Corp. shares gain on results from non-invasive cancer screening test Jun. 23. Cologuard maker Exact.com announces co-exclusive license to co-examine dna-DNA technology. Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. Under its terms, Watchmakers products have the potential to enhance the performance of Exact sciences tests while significantly reducing associated costs. Exact Sciences (NASDAQ:EXAS – Get Free Report ) last released its earnings results on Tuesday, August 1st. CFO Jeffrey Thomas Elliott sold 30,210 shares of Exacts Sciences stock in a transaction that occurred on Monday, August 21st. Exact Sciences Corporation (EXAS) latest stock news & headlines - yahoo finance. exact sciences corporation (exas) latest press releases & corporate news. Markets close in 38 minutes S&P 500 4,462.99 -33.84 (-0.75%) Dow 30 34,453.25 -188.72 (-0.54%) Nasdaq 13,853.41 -167.54 ($47 Bros Oracle evaluation midday hitters offeringsquireilitary cannonsThrow deprivation moving Exact Sciences best-known product is Cologuard, an at-home screening test for colon cancer. The company has about 6,500 employees, roughly 3,000 of whom are in Dane County. Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials. Exact sciences Lab and oncoExtra test Selected by N.C. Cancer Institute. Exact Sciences is focused on developing innovative solutions for cancer detection through non-invasive screening tests. Company remains promising in medical research sector - best stocks. Institutional investors have made changes to their holdings in Exact Sciences, a medical research company. CFO Jeffrey Thomas Elliott recently sold 30,210 shares of the firms stock on August 21st. Insider Brian Baranick sold 1,350 shares on August 7th at an average price."

Keywords

How much time have you spent trying to decide whether investing in Exact Sciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Exact Sciences are: Sciences, Exact, stock, price, EXAS, signal, NASDAQEXAS, and the most common words in the summary are: science, exact, stock, job, price, company, rating, . One of the sentences in the summary was: Exact Sciences Corporation provides cancer screening and diagnostic test products.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #science #exact #stock #job #price #company #rating.

Read more →

Youtube Subscribe

---